6 113 The KND covers an area of about 1,674 square kilometres of land [8] . The area is characterized 114 by a short rainy season and a prolonged dry season from October to March. The mean annual 115 rainfall is about 850mm, with the heaviest usually occurring in August. The total population 116 currently under surveillance is about 152 000 residing in about 32,000 households [8] . Malaria 117 transmission in the KND occurs all year round but there is a distinct seasonal pattern with the peak 118 of transmission coinciding with the period of the major rains (August) and the dry season seeing 119 very low rates of malaria infection [9] .
120 The districts have one district referral hospital located in Navrongo town and 8 health centres 121 strategically located across the district which provide secondary curative and preventive health 122 care. There are 28 Community Based Health Planning and Services (CHPS) compounds/clinics 123 located in various communities and providing primary health care treatment for minor ailments 124 and also carrying out childhood immunizations and antenatal services. There are three private 125 clinics, three pharmacies and over 50 licenced chemical shops in the area.
126 Study design 127 A cross-sectional household survey design was used, and data was collected using quantitative 128 approach. The study was conducted within the INDEPTH-network effectiveness and safety studies 129 (INESS) Phase IV research platform that aimed to assess the effectiveness of new malaria 130 treatments and its determinants in real life health systems [10, 11] . 131 132 Sample size and data collection 133 A standardized, rolling, nested, household survey was used, by employing two-week recall period. 134 We assumed conservatively that at least 6% of the population would have had fever event two 135 weeks prior to the interview date and that about 50% of the population with fever gained access to 136 an official point of ACT provision within 24 hours. We accounted for clustering within households 137 by using a design effect of 1.5. We further allowed a 10% drop out rate to achieve a sample size 138 of 1, 845 households.
139
140 The data for this study were collected as an additional module within the framework of the 141 Navrongo Health and Demographic Surveillance System round updates. Field workers visited the 142 sampled households between July and September 2015. All members in the selected households 143 with a history of fever in the prior two weeks were interviewed using a structured questionnaire.
144 For children who were less than 18 years of age their adult caretakers were interviewed.
145 Information on socio-demographic characteristics, treatment seeking behaviours and cost of 146 treatment were obtained. Cost of treatment was collected from the patient perspective.
147 Those who treated with antimalarial drugs were asked the name of the drug and a physical 148 observation of the drugs if it was still in use or if the package was kept. Field workers carried photo 149 images of the variety of antimalarial packages (brand and generic names) available from private 150 and public providers in the district to facilitate identification of treatments received. Types of 151 antimalarial drugs were to be captured on the questionnaire by their generic names. For instance, 152 brands such as Camosunate, Amonate, Coarsucam, to be captured as Artesunate-Amodiaquine; 196 In-patient or admission was defined as those who were detained in a health facility for malaria for 197 longer than 12 hours. In-patient costs were therefore the sum of medical costs, laboratory costs, Table 5 , the average cost incurred in the treatment of malaria by the uninsured was 276 greater (GH¢43.95/US$11.57) than their insured counterparts (GH¢24.75/US$6.51).
277 The average indirect cost (GH¢25.04/US$6.59) was 1.7 times higher than the direct cost 374 (GH¢14.87/US$3.91). This is consistent with many findings where the indirect costs of malaria 375 treatment were higher than the direct costs of treatment [11, 15, 33, 37, 38] . Therefore, efforts to 376 improve access to health care and reduction of financial burden to households in the treatment of 377 malaria should not only be directed to direct medical costs but also indirect costs.
378
379 Limitations 380 Recall bias is a possible limitation as respondents were asked to recall expenditure over a two 381 weeks period. The reported expenditure could either be overestimated or underestimated especially 382 in cases that respondents did not show receipts on expenditure but reported expenditure verbally.
383 However, because the recall period was short, we do not expect much recall issues to adversely 384 affect the study results.
385
386 In the study, we used self-reported fever or malaria to indicate malaria and we acknowledge that 387 as a limitation. For instance, not all fevers are malaria and also it is possible that some reported 388 malaria cases were really not malaria cases. Nevertheless, given that malaria is endemic in the 389 study area and mostly fever is associated with malaria, we assumed high knowledge about malaria 390 signs and symptoms by respondents would not affect the study findings much. We wish to express our gratitude to the Navrongo Health Research Centre for the institutional 445 support to undertake the study. We are grateful to the study respondents, data collectors, data 446 managers and the data entry clerks for the various support they provided to this study. 
